Phospholipids form the main surface-active layer at the air–liquid interface, while associated proteins contribute to the properties and behavior of that layer. Together, these components allow pulmonary surfactant to spread across the alveolar surface and reduce surface tension. Their combined action helps maintain a stable interface as the lung repeatedly expands and contracts during breathing.
During exhalation, the alveolar surface becomes especially vulnerable to forces that favor collapse. Pulmonary surfactant lowers surface tension at this stage, helping keep alveoli open rather than allowing them to collapse. By stabilizing the air–liquid interface, it also reduces the mechanical work required for the lungs to inflate again during the next breathing cycle.
Surfactant performance depends not only on its presence but also on the composition of its phospholipids and associated proteins. If that composition is altered, the material may not stabilize the alveolar interface effectively. The resulting impairment can increase difficulty with lung inflation and interfere with efficient gas exchange, linking molecular composition to respiratory function.
Surfactant function is relevant wherever a biological surface separates or contacts different phases, such as the air and liquid present in the alveoli. Amphipathic molecules modify interactions at these boundaries, allowing a more stable interface. In biology, this provides a way to connect molecular properties with the physical behavior of tissues exposed to gases and liquids.
Investigating surfactant production and activity can show how the lung acquires and maintains the ability to support breathing. This is particularly relevant to respiratory development, because inadequate production or unsuitable composition can compromise alveolar stability and gas exchange. Such studies also help connect developmental changes in pulmonary surfactant with disease affecting newborn respiratory function.
Surfactant function provides a framework for examining why injured lungs may have impaired mechanical performance or gas exchange. Researchers can consider whether surfactant production or composition has been disrupted and how that disruption affects the alveolar interface. This context supports investigations into therapies for lung injury, while also linking treatment goals to restoration of effective surface stabilization.